BioAdaptives, Inc. (BDPT)

Market Cap	238.97K -3.0%
Revenue (ttm)	7.85K -60.5%
Net Income	-1.11M
EPS	-0.12
Shares Out	12.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,572
Average Volume	34,175
Open	0.0199
Previous Close	0.0199
Day's Range	0.0199 - 0.0199
52-Week Range	0.0131 - 0.1189
Beta	1.15
RSI	48.11
Earnings Date	Mar 27, 2026

About BioAdaptives

BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2013
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: BDPT

Financial Performance

In 2024, BioAdaptives's revenue was $12,669, a decrease of -55.65% compared to the previous year's $28,565. Losses were -$899,161, 26.2% more than in 2023.